December 29, 2018

Walgreens Boots Alliance and Verily strategic partnership

Initially, the companies are developing a medication adherence pilot project that will deploy devices and other approaches designed to improve ad ...

Read More
December 26, 2018

Irish authorities demand €1.6bn in back tax from Perrigo

The Irish tax authority Revenue Commissioners has issued a Notice of Amended Assessment (NoA) to Perrigo stating the company owes €1.64bn ...

Read More
December 26, 2018

Sight-saving treatment for eye infection

A group of scientists from the UK’s University of Birmingham has developed a new eye drop that can minimize sight-threatening scarring to t ...

Read More
December 24, 2018

Big pharma to increase U.S. prices in January

NEW YORK/SAN FRANCISCO (Reuters) — Novartis AG and Bayer AG are among nearly 30 drugmakers that have taken steps to raise the U.S. prices o ...

Read More
December 24, 2018

Vedanta Biosciences Raises $27 Million for microbiome research

US-based Vedanta Biosciences has raised $27 million in a Series C financing to investigate microbiome-derived therapies for several indications, ...

Read More
December 22, 2018

Pharmapack Europe 2019

Pharmapack Europe 2019 is set to showcase the latest innovations when it returns to the Paris Expo Porte de Versailles from 6 - 7 February next y ...

Read More
December 22, 2018

Gilead Sciences and Agenus have announced a partnership

FOSTER CITY, Calif. & LEXINGTON, Mass.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) and Agenus Inc. (NASDAQ: AGEN) announced today ...

Read More
December 20, 2018

GSK plans break-up after £10bn Pfizer deal

GlaxoSmithKline, one of the world’s biggest drugs groups, is to be broken up after the company agreed to spin off its consumer healthcare b ...

Read More
December 20, 2018

Japan-based Taisho Pharmaceutical offers to acquire US-based Bristol-Myers Squibb’s...

The offer from Taisho is structured in the form of a “put option” agreement. Upon exercise of this put option, the Japanese firm w ...

Read More